Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
04.03. | Publicis Health UK promotes Katie McMorran and Clare Middleton as Langland group managing directors | ||
04.03. | Women in pharma | ||
01.03. | UKRI appoints iiCON to deliver £1.5m initiative to tackle infection transmission | ||
01.03. | FDA awards Orphan Drug Designation to SynaptixBio for rare brain disease therapy | ||
01.03. | Sanofi presents positive results for rilzabrutinib in chronic spontaneous urticaria | ||
01.03. | Shaping up for launch in '24: three areas to explore for pharma | ||
29.02. | Radboud researchers use new method to improve diagnosis of rare diseases | ||
29.02. | OneChain-led consortium granted €1.9m to advance CAR-T therapy for rare leukaemia | ||
29.02. | Clinigen launches 'What is Possible?' campaign on Rare Disease Day to accelerate access to medicines | ||
29.02. | CHMP recommends Travere and CSL Vifor's Filspari to treat rare kidney disease IgAN | ||
29.02. | The pharma trailblazer's skill set: forged in rare diseases | ||
29.02. | Rare diseases - driving further improvements in patient access | ||
29.02. | Overcoming challenges in rare disease research with patients | ||
28.02. | BeiGene's tislelizumab receives CHMP recommendation for non-small cell lung cancer | ||
28.02. | ICR study reveals AstraZeneca's ceralasertib sensitises tumours to immunotherapy | ||
28.02. | VML Health announces trio of appointments to creative leadership team | ||
28.02. | Valuable research insights to steer pharma's HCP engagement impact | ||
28.02. | Committing to diversity: the key to pharmaceutical supply chain resilience | ||
28.02. | FDA approves Allecra's combination antibiotic Exblifep for complicated UTIs | ||
27.02. | Novo Nordisk and Neomorph enter molecular glue degrader partnership worth over $1.4bn | ||
27.02. | AstraZeneca's Voydeya receives CHMP recommendation for rare blood disease PNH | ||
27.02. | Novartis and Genentech's Xolair shown to significantly reduce allergic reactions to food | ||
27.02. | Janssen's Carvykti recommended by CHMP for earlier multiple myeloma treatment | ||
27.02. | Researchers develop screening tool to investigate mechanisms behind multiple diseases | ||
27.02. | Landmark project boosts sex and gender equity in UK medical research |